Gazzard B G, Portmann B, Murray-Lyon I M, Williams R
Q J Med. 1975 Oct;44(176):615-26.
The clinical course and causes of death in 132 consecutive patients with fulminant hepatic failure and grade III or IV encephalopathy have been reviewed. 105 patients died and in 96 of these an autopsy examination was performed. In 36 patients there was cerebral oedema and the mean age of this group was significantly younger than the other fatal cases. In 28 patients death was attributed to major haemorrhage which originated in the gastrointestinal tract in 25. The prothrombin time ratio was not significantly greater in patients with major bleeding than in those without but they did have a significantly lower platelet count. Sepsis contributed to death in 12 patients. In 25 patients massive hepatic necrosis only was found at autopsy and death was considered to be due solely to hepatic failure. The degree of hepatocyte loss was assessed in 80 fatal cases by a histological morphometric technique on a needle specimen of liver taken immediately post-mortem. The proportion of the liver volume occupied by hepatocytes (hepatocyte volume fraction, HVF) was greatly reduced in all patients (normal 85+/-SD 5 percent) but the mean value was significantly higher in the patients dying with sepsis, cerebral oedema or haemorrhage than in the group in whom death was attributed solely to hepatic failure. There were ten patients in whom liver function was improving at the time of death which was due to cerebral (9) or haemorrhage (1). These observations suggest that many patients presently dying from fulminant hepatic failure may be expected to survive, once more effective therapy is available for the complications of the illness.
回顾了132例暴发性肝衰竭且伴有III级或IV级脑病患者的临床病程及死因。105例患者死亡,其中96例进行了尸检。36例患者存在脑水肿,该组患者的平均年龄显著低于其他死亡病例。28例患者死于大出血,其中25例大出血起源于胃肠道。大出血患者的凝血酶原时间比值并不显著高于未大出血患者,但血小板计数显著更低。12例患者因脓毒症死亡。25例患者尸检仅发现大片肝坏死,死亡被认为完全是由于肝衰竭。通过组织形态计量学技术,对80例死亡病例死后立即获取的肝脏穿刺标本进行肝细胞损失程度评估。所有患者肝细胞所占肝脏体积比例(肝细胞体积分数,HVF)均大幅降低(正常为85±标准差5%),但死于脓毒症、脑水肿或出血的患者其平均值显著高于仅因肝衰竭死亡的组。有10例患者在死亡时肝功能正在改善,死因分别为脑部病变(9例)或出血(1例)。这些观察结果表明,一旦针对该疾病并发症有更有效的治疗方法,许多目前死于暴发性肝衰竭的患者有望存活。